B-type natriuretic peptide monitoring in the Pediatric ICU population

Paediatric Anaesthesia

Volumn 17, Issue 8, 2007, Pages 793-799

  Tobias, Joseph D ^a,c,d   Lindblade, Christopher L ^b   Schamberger, Marcus S ^b  

^a University of Missouri   (United States)

^b RILEY CHILDREN S HOSPITAL   (United States)

^c Department of Anesthesiology ^*  (United States)

^d Pediatric Anesthesiology   (United States)

Author keywords

Cardiomyopathy; Congenital heart disease; Congestive heart failure; Natriuretic peptides; Septic shock

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; HUMAN; INTENSIVE CARE; MALE; PATIENT MONITORING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MONITORING, PHYSIOLOGIC; NATRIURETIC PEPTIDE, BRAIN;

EID: 34347233110     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02243.x     Document Type: Article

References (38)

1. Marshall J, Berkenbosch JW, Russo P et al. Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 2004 19 : 164 170.
2. Smith T, Rosen D, Russo P et al. Nesiritide during extracorporeal membrane oxygenation. Pediatr Anesth 2005 15 : 152 157.
3. Wheeler A, Tobias JD. Nesiritide in a pediatric oncology patient with renal insufficiency and myocardial dysfunction following septic shock. Pediatr Hematol Oncol 2005 22 : 323 333.
4. Simsic JM, Scheurer M, Tobias JD et al. Perioperative effects and safety of nesiritide following cardiac surgery in children. J Intensive Care Med 2006 21 : 22 26.
5. Rana R, Vlahakis NE, Daniels CE et al. B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med 2006 34 : 1941 1946.
6. Mir TS, Haun C, Lilje C et al. Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open heart surgery. Pediatr Cardiol 2006 27 : 209 216.
7. Shih CY, Sapru A, Oishi P et al. Alterations in b-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker. J Thorac Cardiovasc Surg 2006 131 : 632 636.
8. de Bold AJ, Borenstein HB, Veress AT et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981 28 : 89 94.
9. Forssmann W, Meyer M, Forssmann K. The renal urodilantin system: clinical implications. Cardiovasc Res 2001 51 : 450 452.
10. Mukoyama M, Nakao K, Hosoda K et al. Brain natriuretic peptide as novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991 87 : 1402 1412.
11. Chen HH, Burnett JC. C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J Cardiovasc Pharmacol 1998 32 : S22 S28.
12. Schirger JA, Heublein DM, Chen HH et al. Presence of Dendroaspis natriuretic-peptide like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin Proc 1999 74 : 126 130.
13. Lainchbury JG, Lisy O, Burnett JC Jr. et al. Actions of a novel synthetic natriuretic peptide on hemodynamics and ventricular function in the dog. Am J Physiol 2002 282 : R993 R998.
14. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002 347 : 161 167.
15. Mueller C, Scholer A, Laule-Kilian K et al. Use of B-type natriuretic peptide in evaluation and management of acute dyspnea. N Engl J Med 2004 350 : 647 654.
16. Machado RF, Anthi A, Steinberg MH et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006 296 : 310 318.
17. Koulouri S, Acherman RJ, Wong PC et al. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004 25 : 341 346.
18. Cohen S, Springer C, Avital A et al. Amino-terminal pro-brain-type natriuretic peptide: Heart or lung disease? Pediatrics 2005 115 : 1347 1350.
19. Reynolds EW, Ellington JG, Vranicar M et al. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004 114 : 1297 1304.
20. Puddy YF, Amirmansour C, Williams AF et al. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci 2002 103 : 75 77.
21. Lindblade CL, Chun DS, Darragh RK et al. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients. Am J Cardiol 2005 95 : 909 911.
22. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004 25 : 336 340.
23. Muta H, Ishii M, Maeno Y et al. Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptides before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002 91 : 649 652.
24. Morimoto K, Mori T, Ishiguro S et al. Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Jpn J Surg 1998 28 : 23 29.
25. Georges A, Forestier F, Valli N et al. Changes in type B natriuretic peptide concentrations during cardiac valve surgery. Eur J Cardio Thorac Surg 2004 25 : 941 945.
26. Costello JM, Backer CL, Checchia PA et al. Alterations in the natriuretic hormone system related to cardiopulmonary bypass in infants with congestive heart failure. Pediatr Cardiol 2004 25 : 347 353.
27. Charpentier J, Luyt CE, Fulla Y et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004 32 : 660 665.
28. Rudiger A, Gasser S, Fischler M et al. Comparable increases of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006 34 : 2140 2144.
29. Maeder M, Ammann P, Kiowski W et al. B-type natriuretic peptide in patients with sepsis and preserved left ventricular ejection fraction. Eur J Heart Fail 2005 7 : 1164 1167.
30. Bar S, Swiggum E, Straatman L et al. Nonheart failure associated elevation of amino-terminal pro-brain natriuretic peptide in the setting of sepsis. Can J Cardiol 2006 22 : 263 266.
31. McClean AS, Poh G, Huang SJ. The effect of acute fluid loading on plasma B-type natriuretic peptide levels in a septic shock patient. Anaesth Intensive Care 2005 33 : 528 530.
32. Tung RH, Garcia C, Morss AM et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004 32 : 143 147.
33. Yosdhibayashi M, Kamiya T, Saito Y et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995 133 : 207 209.
34. Mir TS, Marohn S, Laer S et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002 110 : e76.
35. Mir TS, Flato M, Falkenberg J et al. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 2006 27 : 73 77.
36. Chenevier-Gobeaus C, Classens YE, Voyer S et al. Influence of renal function on N-terminal pro-brain natriuretic peptide in patients admitted for dyspnea in the emergency department: comparison with brain natriuretic peptide. Clin Chim Acta 2005 361 : 167 175.
37. Mueller T, Gegenhuber A, Poelz W et al. Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide and amino terminal proBNP. Clin Chem Lab Med 2004 42 : 159 163.
38. Hammerer-Lercher A, Neubauer E, Muller S et al. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 2001 310 : 193 197.